Dimensional Fund Advisors’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-33,696
| Closed | -$1.29M | – | 3354 |
|
|
2024
Q2 | $1.29M | Sell |
33,696
-34,448
| -51% | -$1.32M | ﹤0.01% | 2867 |
|
|
2024
Q1 | $4.01M | Buy |
68,144
+32,577
| +92% | +$1.91M | ﹤0.01% | 2602 |
|
|
2023
Q4 | $2.13M | Buy |
35,567
+9,500
| +36% | +$569K | ﹤0.01% | 2779 |
|
|
2023
Q3 | $992K | Sell |
26,067
-105,720
| -80% | -$4.02M | ﹤0.01% | 2930 |
|
|
2023
Q2 | $12M | Buy |
131,787
+37,801
| +40% | +$3.44M | ﹤0.01% | 2171 |
|
|
2023
Q1 | $6.2M | Buy |
93,986
+52,979
| +129% | +$3.49M | ﹤0.01% | 2413 |
|
|
2022
Q4 | $2.12K | Sell |
41,007
-41,587
| -50% | -$2.15K | ﹤0.01% | 2716 |
|
|
2022
Q3 | $5.64M | Buy |
+82,594
| New | +$5.64M | ﹤0.01% | 2385 |
|
|
2022
Q1 | – | Sell |
-9,828
| Closed | -$465K | – | 3510 |
|
|
2021
Q4 | $465K | Sell |
9,828
-574
| -6% | -$27.2K | ﹤0.01% | 3182 |
|
|
2021
Q3 | $343K | Buy |
+10,402
| New | +$343K | ﹤0.01% | 3251 |
|